Cue Biopharma

CUE · NASDAQ

$17.04+$0.96 (+5.97%)TodayMarket closed · Oct 20, 7:57 PM ET

Prev close $16.08

Latest news

NewsSep 21, 10:45 AM ETVandana Singh
What's Going on With Cue Biopharma Stock on Monday?
NewsSep 21, 5:01 AM ETAvi Kapoor
Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Press releaseSep 20, 6:00 AM ETGlobe Newswire
Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria
Press releaseAug 24, 9:05 AM ETPRNewswire
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Cue Biopharma, Inc. (NASDAQ: CUE)
NewsAug 14, 5:06 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
Press releaseAug 14, 4:05 PM ETGlobe Newswire
Cue Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Press releaseAug 3, 8:30 AM ETGlobe Newswire
Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission
Press releaseJul 13, 8:30 AM ETGlobe Newswire
Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development
NewsJun 23, 1:05 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
Press releaseJun 2, 4:05 PM ETGlobe Newswire
Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution
Press releaseMay 14, 4:07 PM ETGlobe Newswire
Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments
NewsMay 1, 5:05 PM ET
12 Health Care Stocks Moving In Friday's After-Market Session
NewsMay 1, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsMay 1, 7:16 AM ET
Market-Moving News for May 1st
NewsMay 1, 4:36 AM ETAvi Kapoor
Why Twilio Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
NewsMay 1, 1:40 AM ETMohd Haider
Cue Biopharma Stock Surges Over 65% Overnight: Why Is It Moving?
NewsApr 30, 5:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseApr 30, 4:15 PM ETGlobe Newswire
Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody
Press releaseApr 30, 4:05 PM ETGlobe Newswire
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
NewsApr 22, 12:23 PM ETAlex Perry
What's Behind The Drop In Cue Biopharma Stock Today?
Press releaseApr 22, 8:37 AM ETGlobe Newswire
Cue Biopharma Announces 1-for-30 Reverse Stock Split
NewsApr 20, 1:05 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
NewsApr 9, 8:05 AM ET
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press releaseMar 26, 8:00 AM ETGlobe Newswire
Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026
NewsMar 16, 5:05 PM ET
12 Health Care Stocks Moving In Monday's After-Market Session
NewsNov 19, 7:05 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Press releaseNov 13, 1:10 PM ETBusiness Wire
Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments
NewsNov 3, 7:05 AM ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
NewsOct 9, 5:06 PM ET
12 Health Care Stocks Moving In Thursday's After-Market Session
Press releaseAug 21, 8:00 AM ETGlobe Newswire
Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference
Press releaseJul 23, 9:26 AM ETPRNewswire
High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds
Press releaseMay 12, 4:05 PM ETGlobe Newswire
Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights
Press releaseMay 8, 8:00 AM ETGlobe Newswire
Cue Biopharma to Host Virtual Investor Event on May 15, 2025
Press releaseMay 5, 10:00 AM ETGlobe Newswire
Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference
NewsNov 8, 1:32 PM ET
Cue Biopharma Shares Phase 1 Data At SITC 2024; CUE-101 Shows 46% ORR And 91.3% 12-Month OS In Head And Neck Cancer, CUE-102 Demonstrates 67% DCR In Late-Stage Pancreatic Cancer
NewsOct 30, 8:08 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
NewsOct 30, 8:08 AM ET
12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

What's Going on With Cue Biopharma Stock on Monday?

Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket

Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Cue Biopharma, Inc. (NASDAQ: CUE)

12 Health Care Stocks Moving In Friday's After-Market Session

Cue Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Cue Biopharma Announces Appointment of James M. Ahlers as Chief Financial Officer and CUE-221 Investigational New Drug Submission

Cue Biopharma Appoints Dominic Borie, M.D., Ph.D., as Chief Medical Officer and Head of Research & Development

12 Health Care Stocks Moving In Tuesday's Intraday Session

Cue Biopharma Announces Board Transition and Addition of New Directors with Continued Company Evolution

Cue Biopharma Reports First Quarter 2026 Financial Results and Recent Strategic Developments

12 Health Care Stocks Moving In Friday's After-Market Session

12 Health Care Stocks Moving In Friday's Pre-Market Session

Market-Moving News for May 1st

Why Twilio Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket

Cue Biopharma Stock Surges Over 65% Overnight: Why Is It Moving?

12 Health Care Stocks Moving In Thursday's After-Market Session

Cue Biopharma Expands Pipeline with Exclusive License from Ascendant Health Sciences Ltd. for Clinical-Stage Dual-Mechanism Anti-IgE Antibody

Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company

What's Behind The Drop In Cue Biopharma Stock Today?

Cue Biopharma Announces 1-for-30 Reverse Stock Split

12 Health Care Stocks Moving In Monday's Intraday Session

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Cue Biopharma to Host Virtual R&D Day Event on April 7, 2026

12 Health Care Stocks Moving In Monday's After-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Singapore-based ImmunoScape Pioneers Next-Generation Cell Therapy for Solid Tumors; Announces Key Licensing Deal, New Board and SAB Appointments

12 Health Care Stocks Moving In Monday's Pre-Market Session

12 Health Care Stocks Moving In Thursday's After-Market Session

Cue Biopharma to Participate in Fireside Chat at the Cantor Global Healthcare Conference

High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds

Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights

Cue Biopharma to Host Virtual Investor Event on May 15, 2025

Cue Biopharma to Participate in Fireside Chat at the Citizens Life Sciences Conference

Cue Biopharma Shares Phase 1 Data At SITC 2024; CUE-101 Shows 46% ORR And 91.3% 12-Month OS In Head And Neck Cancer, CUE-102 Demonstrates 67% DCR In Late-Stage Pancreatic Cancer

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's Pre-Market Session